Active pharmaceutical ingredients are biologically active components of a medicine which are mainly responsible for causing effects. The API’s are generally manufactured through a variety of processes which include chemical synthesis, fermentation process, recombinant DNA technology, Isolation, and recovery from natural sources. From the past few decades, the necessity to produce active pharmaceutical ingredients on… Continue reading BIOTECH API DRIVING THE ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET
Biologics include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Contract biomanufacturing is a widely used term to describe the manufacture of biologic molecules for various stages of drug development right from pre-clinical stage to commercial supply. The biologic drug manufacturing… Continue reading Current Trends in Contract Biomanufacturing Services Global Market
NASH is a severe, progressive liver disease characterized by the accumulation of excessive fat in the liver. It is associated with inflammation, hepatocyte injury and fibro-genesis, and may worsen into fibrosis/cirrhosis, liver failure and rarely into liver cancer. NASH is the second leading cause for liver damage and considered to be the rapidly growing reason… Continue reading Latest Developments in NASH (Nonalcoholic Steatohepatitis) Pipeline.